{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:18:29Z","timestamp":1793488709013,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T00:00:00Z","timestamp":1470182400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00393-016-0105-3","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T07:40:13Z","timestamp":1470210013000},"page":"687-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Diagnostik und Therapie der Polymyalgia rheumatica","Diagnostics and treatment of polymyalgia rheumatica"],"prefix":"10.1007","volume":"75","author":[{"given":"C.","family":"Dejaco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Buttgereit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,3]]},"reference":[{"key":"105_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0140-6736(12)60680-1","volume":"381","author":"TA Kermani","year":"2013","unstructured":"Kermani TA, Warrington KJ (2013) Polymyalgia rheumatica. Lancet 381:63\u201372. doi:10.1016\/S0140-6736(12)60680-1","journal-title":"Lancet"},{"key":"105_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1056\/NEJMcp1214825","volume":"371","author":"CM Weyand","year":"2014","unstructured":"Weyand CM, Goronzy JJ (2014) Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 371:50\u201357. doi:10.1056\/NEJMcp1214825","journal-title":"N Engl J Med"},{"key":"105_CR3","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1136\/ard.2009.111005","volume":"69","author":"TA Kermani","year":"2010","unstructured":"Kermani TA, Schafer VS, Crowson CS et al (2010) Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis 69:780\u2013781. doi:10.1136\/ard.2009.111005","journal-title":"Ann Rheum Dis"},{"key":"105_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/NEJMra022694","volume":"349","author":"CM Weyand","year":"2003","unstructured":"Weyand CM, Goronzy JJ (2003) Medium- and large-vessel vasculitis. N Engl J Med 349:160\u2013169. doi:10.1056\/NEJMra022694","journal-title":"N Engl J Med"},{"key":"105_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/art.30155","volume":"63","author":"CS Crowson","year":"2011","unstructured":"Crowson CS, Matteson EL, Myasoedova E et al (2011) The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 63:633\u2013639. doi:10.1002\/art.30155","journal-title":"Arthritis Rheum"},{"key":"105_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG et\u00a0al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part\u00a0II. Arthritis Rheum 58:26\u201335. doi:10.1002\/art.23176","journal-title":"Arthritis Rheum"},{"key":"105_CR7","first-page":"S9","volume":"18","author":"MA Cimmino","year":"2000","unstructured":"Cimmino MA, Zaccaria A (2000) Epidemiology of polymyalgia rheumatica. Clin Exp Rheumatol 18:S9\u2013S11","journal-title":"Clin Exp Rheumatol"},{"key":"105_CR8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0034-1383661","volume":"39","author":"C Dejaco","year":"2014","unstructured":"Dejaco C, Wagner AD (2014) Aetiology and pathogenesis of polymyalgia rheumatica and giant-cell arteritis. Akt Rheumatol 39:256\u2013260","journal-title":"Akt Rheumatol"},{"key":"105_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","volume":"372","author":"C Salvarani","year":"2008","unstructured":"Salvarani C, Cantini F, Hunder GG (2008) Polymyalgia rheumatica and giant-cell arteritis. Lancet 372:234\u2013245. doi:10.1016\/S0140-6736(08)61077-6","journal-title":"Lancet"},{"key":"105_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00108-008-2274-x","volume":"50","author":"C Duftner","year":"2009","unstructured":"Duftner C, Dejaco C, Schirmer M (2009) Polymyalgia rheumatica. Internist 50:51\u201359. doi:10.1007\/s00108-008-2274-x","journal-title":"Internist"},{"key":"105_CR11","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/art.34356","volume":"64","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Kremers HM et\u00a0al (2012) 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Arthritis Rheum 64:943\u2013954. doi:10.1002\/art.34356","journal-title":"Arthritis Rheum"},{"key":"105_CR12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"71","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H et al (2012) 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71:484\u2013492. doi:10.1136\/annrheumdis-2011-200329","journal-title":"Ann Rheum Dis"},{"key":"105_CR13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","volume":"38","author":"HA Bird","year":"1979","unstructured":"Bird HA, Esselinckx W, Dixon AS et\u00a0al (1979) An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434\u2013439","journal-title":"Ann Rheum Dis"},{"key":"105_CR14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","volume":"97","author":"TY Chuang","year":"1982","unstructured":"Chuang TY, Hunder GG, Ilstrup DM, Kurland LT (1982) Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 97:672\u2013680","journal-title":"Ann Intern Med"},{"key":"105_CR15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0049-0172(84)90012-X","volume":"13","author":"LA Healey","year":"1984","unstructured":"Healey LA (1984) Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 13:322\u2013328","journal-title":"Semin Arthritis Rheum"},{"key":"105_CR16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/ard.60.11.1021","volume":"60","author":"R Caporali","year":"2001","unstructured":"Caporali R, Montecucco C, Epis O et al (2001) Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study. Ann Rheum Dis 60:1021\u20131024","journal-title":"Ann Rheum Dis"},{"key":"105_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.archger.2005.07.003","volume":"42","author":"N Turkcapar","year":"2006","unstructured":"Turkcapar N, Demir O, Atli T et\u00a0al (2006) Late onset rheumatoid arthritis: clinical and laboratory comparisons with younger onset patients. Arch Gerontol Geriatr 42:225\u2013231. doi:10.1016\/j.archger.2005.07.003","journal-title":"Arch Gerontol Geriatr"},{"key":"105_CR18","doi-asserted-by":"publisher","first-page":"R119","DOI":"10.1186\/ar2008","volume":"8","author":"C Dejaco","year":"2006","unstructured":"Dejaco C, Klotz W, Larcher H et\u00a0al (2006) Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Res Ther 8:R119 doi:10.1186\/ar2008","journal-title":"Arthritis Res Ther"},{"key":"105_CR19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/rheumatology\/keh143","volume":"43","author":"M Lopez-Hoyos","year":"2004","unstructured":"Lopez-Hoyos M, Ruiz de Alegria C, Blanco R et al (2004) Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Rheumatology 43:655\u2013657. doi:10.1093\/rheumatology\/keh143","journal-title":"Rheumatology"},{"key":"105_CR20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2217\/ahe.11.50","volume":"7","author":"C Dejaco","year":"2011","unstructured":"Dejaco C, Duftner C, Dasgupta B et\u00a0al (2011) Polymyalgia rheumatica and giant cell arteritis: management of two diseases of the elderly. Aging Health 7:633\u2013645. doi:10.2217\/ahe.11.50","journal-title":"Aging Health"},{"key":"105_CR21","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.39333","volume":"67","author":"C Dejaco","year":"2015","unstructured":"Dejaco C, Singh YP, Perel P et\u00a0al (2015) 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Arthritis Rheumatol 67:2569\u20132580. doi:10.1002\/art.39333","journal-title":"Arthritis Rheumatol"},{"key":"105_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00393-004-0597-0","volume":"63","author":"P Schneider","year":"2004","unstructured":"Schneider P, Schneider I (2004) Calcium pyrophosphate dihydrate-crystal induced arthropathy. Z Rheumatol 63:10\u201321. doi:10.1007\/s00393-004-0597-0","journal-title":"Z Rheumatol"},{"key":"105_CR23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/ard.50.5.321","volume":"50","author":"ND Hopkinson","year":"1991","unstructured":"Hopkinson ND, Shawe DJ, Gumpel JM (1991) Polymyositis, not polymyalgia rheumatica. Ann Rheum Dis 50:321\u2013322","journal-title":"Ann Rheum Dis"},{"key":"105_CR24","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00296-007-0331-8","volume":"27","author":"I Olivieri","year":"2007","unstructured":"Olivieri I, Garcia-Porrua C, Padula A et al (2007) Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases. Rheumatol Int 27:927\u2013933. doi:10.1007\/s00296-007-0331-8","journal-title":"Rheumatol Int"},{"key":"105_CR25","first-page":"S34","volume":"18","author":"VM Mart\u00ednez-Taboada","year":"2000","unstructured":"Mart\u00ednez-Taboada VM, Blanco R, Rodr\u00edguez-Valverde V (2000) Polymyalgia rheumatica with normal erythrocyte sedimentation rate: clinical aspects. Clin Exp Rheumatol 18:S34\u2013S37","journal-title":"Clin Exp Rheumatol"},{"key":"105_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/ard.2008.103663","volume":"69","author":"L Alvarez-Rodr\u00edguez","year":"2010","unstructured":"Alvarez-Rodr\u00edguez L, Lopez-Hoyos M, Mata C et al (2010) Circulating cytokines in active polymyalgia rheumatica. Ann Rheum Dis 69:263\u2013269. doi:10.1136\/ard.2008.103663","journal-title":"Ann Rheum Dis"},{"key":"105_CR27","first-page":"1049","volume":"28","author":"F Cantini","year":"2001","unstructured":"Cantini F, Salvarani C, Olivieri I et al (2001) Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. J Rheumatol 28:1049\u20131055","journal-title":"J Rheumatol"},{"key":"105_CR28","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/1529-0131(200105)44:53.0.co;2-n","volume":"44","author":"F Cantini","year":"2001","unstructured":"Cantini F, Salvarani C, Olivieri I et al (2001) Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate. Arthritis Rheum 44:1155\u20131159. doi:10.1002\/1529-0131(200105)44:53.0.co;2-n","journal-title":"Arthritis Rheum"},{"key":"105_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/03009742.2010.486766","volume":"40","author":"P Falsetti","year":"2011","unstructured":"Falsetti P, Acciai C, Volpe A, Lenzi L (2011) Ultrasonography in early assessment of elderly patients with polymyalgic symptoms: a role in predicting diagnostic outcome? Scand J Rheumatol 40:57\u201363. doi:10.3109\/03009742.2010.486766","journal-title":"Scand J Rheumatol"},{"key":"105_CR30","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1136\/ard.2007.084723","volume":"67","author":"C Salvarani","year":"2008","unstructured":"Salvarani C, Barozzi L, Cantini F et\u00a0al (2008) Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis 67:758\u2013761. doi:10.1136\/ard.2007.084723","journal-title":"Ann Rheum Dis"},{"key":"105_CR31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","volume":"46","author":"D Blockmans","year":"2007","unstructured":"Blockmans D, Ceuninck L de, Vanderschueren S et al (2007) Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology 46:672\u2013677. doi:10.1093\/rheumatology\/kel376","journal-title":"Rheumatology"},{"key":"105_CR32","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","volume":"74","author":"C Dejaco","year":"2015","unstructured":"Dejaco C, Singh YP, Perel P et al (2015) 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 74:1799\u20131807. doi:10.1136\/annrheumdis-2015-207492","journal-title":"Ann Rheum Dis"},{"key":"105_CR33","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/ard.48.8.662","volume":"48","author":"V Kyle","year":"1989","unstructured":"Kyle V, Hazleman BL (1989) Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis 48:662\u2013666","journal-title":"Ann Rheum Dis"},{"key":"105_CR34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/ard.47.9.733","volume":"47","author":"G Delecoeuillerie","year":"1988","unstructured":"Delecoeuillerie G, Joly P, Cohen de Lara A, Paolaggi JB (1988) Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis 47:733\u2013739","journal-title":"Ann Rheum Dis"},{"key":"105_CR35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/ard.48.8.658","volume":"48","author":"V Kyle","year":"1989","unstructured":"Kyle V, Hazleman BL (1989) Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis 48:658\u2013661","journal-title":"Ann Rheum Dis"},{"key":"105_CR36","volume-title":"Rationelle Diagnostik und Therapie der Inneren Medizin: Leitlinien-basierte Empfehlungen f\u00fcr die Praxis","author":"WA Schmidt","year":"2011","unstructured":"Schmidt WA, Gromnica-Ihle E (2011) Polymyalgia rheumatica und Riesenzellarteriitis (Arteriitis temporalis). In: Fleig O, Fleig WE, Mayet WJ, Mertens PR, Meyer J, M\u00fcller OA, Pfeifer M, Pletz MW, Weiss N (Hrsg) Rationelle Diagnostik und Therapie der Inneren Medizin: Leitlinien-basierte Empfehlungen f\u00fcr die Praxis. Elsevier, M\u00fcnchen"},{"key":"105_CR37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/37.2.189","volume":"37","author":"B Dasgupta","year":"1998","unstructured":"Dasgupta B, Dolan AL, Panayi GS, Fernandes L (1998) An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica. Br J Rheumatol 37:189\u2013195","journal-title":"Br J Rheumatol"},{"key":"105_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","volume":"49","author":"B Dasgupta","year":"2010","unstructured":"Dasgupta B, Borg FA, Hassan N et\u00a0al (2010) BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology 49:186\u2013190. doi:10.1093\/rheumatology\/kep303a","journal-title":"Rheumatology"},{"key":"105_CR39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","volume":"141","author":"R Caporali","year":"2004","unstructured":"Caporali R, Cimmino MA, Ferraccioli G et al (2004) Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 141:493\u2013500","journal-title":"Ann Intern Med"},{"key":"105_CR40","first-page":"395","volume":"26","author":"MA Cimmino","year":"2008","unstructured":"Cimmino MA, Salvarani C, Macchioni P et al (2008) Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids. Clin Exp Rheumatol 26:395\u2013400","journal-title":"Clin Exp Rheumatol"},{"key":"105_CR41","first-page":"624","volume":"23","author":"G Ferraccioli","year":"1996","unstructured":"Ferraccioli G, Salaffi F, De Vita S et\u00a0al (1996) Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J\u00a0Rheumatol 23:624\u2013628","journal-title":"J Rheumatol"},{"key":"105_CR42","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00296-012-2580-4","volume":"33","author":"JH Lee","year":"2013","unstructured":"Lee JH, Choi ST, Kim JS et al (2013) Clinical characteristics and prognostic factors for relapse in patients with polymyalgia rheumatica (PMR). Rheumatol Int 33:1475\u20131480. doi:10.1007\/s00296-012-2580-4","journal-title":"Rheumatol Int"},{"key":"105_CR43","first-page":"265","volume":"14","author":"AM Nazarinia","year":"2012","unstructured":"Nazarinia AM, Moghimi J, Toussi J (2012) Efficacy of methotrexate in patients with polymyalgia rheumatica. Koomesh 14:265\u2013270","journal-title":"Koomesh"},{"key":"105_CR44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.55.4.218","volume":"55","author":"MJ Veen van der","year":"1996","unstructured":"Veen MJ van der, Dinant HJ, Booma-Frankfort C van et al (1996) Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? Ann Rheum Dis 55:218\u2013223 (Erratum appears in Ann Rheum Dis 1996 Aug;55(8):563)","journal-title":"Ann Rheum Dis"},{"key":"105_CR45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.45.2.136","volume":"45","author":"M Silva De","year":"1986","unstructured":"De Silva M, Hazleman BL (1986) Azathioprine in giant cell arteritis\/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis 45:136\u2013138","journal-title":"Ann Rheum Dis"},{"key":"105_CR46","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/j.1742-1241.2012.02981.x","volume":"66","author":"T Adizie","year":"2012","unstructured":"Adizie T, Christidis D, Dharmapaliah C et al (2012) Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series. Int J Clin Pract 66:906\u2013909. doi:10.1111\/j.1742-1241.2012.02981.x","journal-title":"Int J Clin Pract"},{"key":"105_CR47","doi-asserted-by":"publisher","first-page":"120638","DOI":"10.1155\/2013\/120638","volume":"2013","author":"AP Diamantopoulos","year":"2013","unstructured":"Diamantopoulos AP, Hetland H, Myklebust G (2013) Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series. Biomed Res Int 2013:120638 doi:10.1155\/2013\/120638","journal-title":"Biomed Res Int"},{"key":"105_CR48","unstructured":"Devauchelle V, Saraux A, Berthelot J et\u00a0al (2015) Dramatic efficacy of Tocilizumab as first line therapy in patients with recent polymyalgia rheumatica (PMR): results of the first longitudinal prospective study. Arthritis Rheumatol. Abstr 1987"},{"key":"105_CR49","unstructured":"Lally L, Forbess L, Hatzis C, Spiera R (2015) Efficacy and safety of Tocilizumab for the treatment of polymyalgia rheumatica. Arthritis Rheumatol. Abstr 3144"},{"key":"105_CR50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.semarthrit.2013.01.003","volume":"43","author":"P Macchioni","year":"2013","unstructured":"Macchioni P, Boiardi L, Catanoso M et\u00a0al (2013) Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature. Semin Arthritis Rheum 43:113\u2013118. doi:10.1016\/j.semarthrit.2013.01.003","journal-title":"Semin Arthritis Rheum"},{"key":"105_CR51","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/RHU.0b013e3182a6aa0e","volume":"19","author":"AA Rashidi","year":"2013","unstructured":"Rashidi AA, Hegazi MO, Mohammad SA, Varghese A (2013) Effective control of polymyalgia rheumatica with tocilizumab. J\u00a0Clin Rheumatol 19:400\u2013401. doi:10.1097\/RHU.0b013e3182a6aa0e","journal-title":"J Clin Rheumatol"},{"key":"105_CR52","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/annrheumdis-2015-eular.5377","volume":"74","author":"E Toussirot","year":"2015","unstructured":"Toussirot E, Martin A, Soubrier M et al (2015) Clinical efficacy of tocilizumab in polymyalgia rheumatica: an open-label study. Ann Rheum Dis 74:516","journal-title":"Ann Rheum Dis"},{"key":"105_CR53","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/ard.2010.133850","volume":"70","author":"C Dejaco","year":"2011","unstructured":"Dejaco C, Duftner C, Cimmino MA et al (2011) Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis 70:447\u2013453. doi:10.1136\/ard.2010.133850","journal-title":"Ann Rheum Dis"},{"key":"105_CR54","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/ard.2003.011379","volume":"63","author":"BF Leeb","year":"2004","unstructured":"Leeb BF, Bird HA (2004) A disease activity score for polymyalgia rheumatica. Ann Rheum Dis 63:1279\u20131283. doi:10.1136\/ard.2003.011379","journal-title":"Ann Rheum Dis"},{"key":"105_CR55","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1136\/ard.2002.002618","volume":"62","author":"BF Leeb","year":"2003","unstructured":"Leeb BF, Bird HA, Nesher G et\u00a0al (2003) EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT). Ann Rheum Dis 62:1189\u20131194","journal-title":"Ann Rheum Dis"},{"key":"105_CR56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/ar2685","volume":"11","author":"FA Borg","year":"2009","unstructured":"Borg FA, Dasgupta B (2009) Peripheral arterial disease in polymyalgia rheumatica. Arthritis Res Ther 11:111 doi:10.1186\/ar2685","journal-title":"Arthritis Res Ther"},{"key":"105_CR57","doi-asserted-by":"publisher","first-page":"R50","DOI":"10.1186\/ar2664","volume":"11","author":"KJ Warrington","year":"2009","unstructured":"Warrington KJ, Jarpa EP, Crowson CS et al (2009) Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study. Arthritis Res Ther 11:R50 doi:10.1186\/ar2664","journal-title":"Arthritis Res Ther"},{"key":"105_CR58","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/1529-0131(199710)40:10&lt;1873::AID-ART22&gt;3.0.CO;2-V","volume":"40","author":"SE Gabriel","year":"1997","unstructured":"Gabriel SE, Sunku J, Salvarani C et al (1997) Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 40:1873\u20131878. doi:10.1002\/1529-0131(199710)40:10<1873::AID-ART22>3.0.CO;2-V","journal-title":"Arthritis Rheum"},{"key":"105_CR59","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/art.11388","volume":"49","author":"A Proven","year":"2003","unstructured":"Proven A, Gabriel SE, Orces C et\u00a0al (2003) Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 49:703\u2013708. doi:10.1002\/art.11388","journal-title":"Arthritis Rheum"},{"key":"105_CR60","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1136\/ard.2009.114579","volume":"69","author":"MC Goes van der","year":"2010","unstructured":"Goes MC van der, Jacobs JW, Boers M et\u00a0al (2010) Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 69:1015\u20131021. doi:10.1136\/ard.2009.114579","journal-title":"Ann Rheum Dis"},{"key":"105_CR61","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1136\/ard.2007.072157","volume":"66","author":"JN Hoes","year":"2007","unstructured":"Hoes JN, Jacobs JWG, Boers M et al (2007) EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 66:1560\u20131567. doi:10.1136\/ard.2007.072157","journal-title":"Ann Rheum Dis"},{"key":"105_CR62","doi-asserted-by":"publisher","first-page":"003","DOI":"10.4172\/2161-1149.S6-003","volume":"S6","author":"EC Pfeifer","year":"2015","unstructured":"Pfeifer EC, Crowson CS, Major BT, Matteson EL (2015) Polymyalgia rheumatica and its association with cancer. Rheumatology S6:003 doi:10.4172\/2161-1149.S6-003","journal-title":"Rheumatology"},{"key":"105_CR63","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.semarthrit.2014.06.004","volume":"44","author":"P Ungprasert","year":"2014","unstructured":"Ungprasert P, Sanguankeo A, Upala S, Knight EL (2014) Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis. Semin Arthritis Rheum 44:366\u2013370. doi:10.1016\/j.semarthrit.2014.06.004","journal-title":"Semin Arthritis Rheum"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0105-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-016-0105-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0105-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:51:05Z","timestamp":1498319465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-016-0105-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,3]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1007\/s00393-016-0105-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,3]]}}}